ZULATO, ELISABETTA

ZULATO, ELISABETTA  

Mostra records
Risultati 1 - 20 di 21 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features 2021 Dal Maso, A.Zulato, E.Fassan, M.Pasello, G.Guarneri, V.Calabrese, F.Rea, F.Indraccolo, S.Conte, P. F. + JOURNAL OF THORACIC ONCOLOGY - -
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: Predictive value of DNA-PK and phosphorylated ACC 2016 Perrone F.Baldassarre G.Indraccolo S.Sonego M.Zulato E.Scollo P. + ONCOTARGET - -
CARATTERIZZAZIONE GENETICA E FUNZIONALE DI FIBROBLASTI ISOLATI DA PAZIENTI AFFETTI DA SINDROME DI ALSTROM 2010 ZULATO, ELISABETTA - - -
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 2019 Pasello, GiuliaDal Maso, AlessandroLorenzi, MartinaScattolin, DanielaUrso, LoredanaZulato, ElisabettaFrega, StefanoIndraccolo, StefanoCalabrese, FiorellaConte, Pierfranco + JOURNAL OF CLINICAL ONCOLOGY - -
Detection of loss of heterozygosity in cfDNA of advanced EGFR-or KRAS-mutated non-small-cell lung cancer patients 2020 Nardo G.Zulato E.Frega S.Indraccolo S. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors 2021 Marra, LudovicaBoscolo, AliceDal Maso, AlessandroBoscolo Bragadin, AndreaIndraccolo, StefanoZulato, Elisabetta + FRONTIERS IN ONCOLOGY - -
Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer 2020 Zulato, ElisabettaAttili, IlariaPavan, AlbertoDel Bianco, PaolaBoscolo Bragadin, AndreaPasello, GiuliaFassan, MatteoCalabrese, FiorellaGuarneri, ValentinaAmadori, AlbertoConte, PierFrancoIndraccolo, Stefano + BRITISH JOURNAL OF CANCER - -
EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience 2022 Dal Maso, ADel Bianco, PNardo, GZulato, EPasello, GIndraccolo, S + JOURNAL OF THORACIC DISEASE - -
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 2021 Urso L.Vernaci G.Fassan M.Zulato E.Faggioni G.Menichetti A.Di Liso E.Griguolo G.Conte P.Indraccolo S.Guarneri V.Dieci M. V. + FRONTIERS IN ONCOLOGY - -
Implementation of next generation sequencing-based liquid biopsy for clinical molecular diagnostics in non-small cell lung cancer (Nsclc) patients 2021 Zulato E.Tosello V.Nardo G.Del Bianco P.Indraccolo S. + DIAGNOSTICS - -
In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach 2020 Piga I.Montenegro F.Nardo G.Zulato E.Del Bianco P.Indraccolo S. + FRONTIERS IN ONCOLOGY - -
Involvement of NADPH Oxidase 1 in Liver Kinase B1-mediated effects on tumor angiogenesis and growth 2018 Elisabetta ZulatoFrancesco CiccareseMarica PinazzaValentina AgnusdeiMicol Silic-BenussiVincenzo CiminaleStefano Indraccolo + FRONTIERS IN ONCOLOGY - -
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? 2022 Dal Maso, AlessandroZulato, ElisabettaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, Stefano + BRITISH JOURNAL OF CANCER - -
LKB1 expression correlates with increased survival in advanced non-small cell lung cancer patients treated with chemotherapy and bevacizumab 2017 Bonanno, LauraDe Paoli, AngelaZulato, ElisabettaCALABRESE, FIORELLAFavaretto, AdolfoSanto, AntonioCICCARESE, FRANCESCOBertorelle, RobertaDe Salvo, Gian LucaAMADORI, ALBERTOConte, PierfrancoIndraccolo, Stefano + CLINICAL CANCER RESEARCH - -
LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective 2019 Ciccarese F.Zulato E.Indraccolo S. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY - -
Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC 2018 Zulato E.Indraccolo S. + JOURNAL OF THORACIC ONCOLOGY - -
Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome 2020 Zulato, ElisabettaFerro, AlessandraBoscolo, AliceAttili, IlariaFrega, StefanoDal Maso, AlessandroPasello, GiuliaGuarneri, ValentinaConte, Pier FrancoIndraccolo, Stefano + JOURNAL OF CLINICAL ONCOLOGY - -
Potentialities of liquid biopsy in advanced non-small cell lung cancer (aNSCLC): Early evaluation of sentinel mutations in plasma and outcome of patients treated with immunotherapy 2019 Zulato, E.Attili, I.Del Bianco, P.Nardo, G.Boscolo Bragadin, A.Pasqualini, L.Calabrese, F.Fassan, M.Pasello, G.Guarneri, V.Conte, P.Indraccolo, S. + ANNALS OF ONCOLOGY - -
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome 2021 Boscolo Bragadin, AndreaZulato, ElisabettaAttili, IlariaDal Maso, AlessandroFrega, StefanoFassan, MatteoCalabrese, FiorellaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, Stefano + TRANSLATIONAL LUNG CANCER RESEARCH - -
Therapeutic concentrations of digitoxin inhibit endothelial focal adhesion kinase and angiogenesis induced by diverse growth factors 2017 TRENTI, ANNALISAZULATO, ELISABETTAINDRACCOLO, STEFANOBOLEGO, CHIARATREVISI, LUCIA + BRITISH JOURNAL OF PHARMACOLOGY - -